#本文僅代表作者觀點,不代表IPRdaily立場#
“藥明巨諾(港交所代碼:2126)是一家獨立的、專注于開發(fā)、生產及商業(yè)化細胞免疫治療產品的創(chuàng)新型生物科技公司?,F(xiàn)根據發(fā)展需求招聘高級知識產權顧問。”
來源:IPRdaily中文網(iprdaily.cn)
提示:“聘”欄目為四二六人才平臺(426.cn)【人力資源服務許可證編號:(粵)人服證字(2022)第0112005723號】,針對于企事業(yè)單位、服務機構、律師事務所開辟的知識產權人才專欄,如果您有招聘需求,可將招聘需求發(fā)送至zhaopin@426.cn。
高級知識產權顧問
Senior IP Consultant
職責:
Responsibilities:
1. 許可協(xié)議審查:對公司與其他方簽訂的許可協(xié)議(license agreement)進行全面審查。從這些協(xié)議中提取關鍵條款和內容,并就必要的后續(xù)行動提供指導。
1.Review of License Agreements: Conduct a thorough review of license agreements entered into by the company and with other parties. Abstract key terms and content from these agreements and provide guidance on necessary follow-up actions.
2. 知識產權結構分析:分析組織內部當前的知識產權結構。確?,F(xiàn)有知識產權資產的持續(xù)維護,并防止知識產權申請?zhí)峤换蛳蛳嚓P當局支付款項的任何延誤。
2.IP Structure Analysis: Analyze the current intellectual property structure within the organization. Ensure the ongoing maintenance of existing IP assets and prevent any delays in IP application submissions or payments to relevant authorities.
3. 支持知識產權相關項目:協(xié)助開發(fā)和產品團隊處理與知識產權相關的任務。就各種國家和地區(qū)的知識產權權利應用提供專業(yè)建議。
3.Support for IP-Related Initiatives: Assist with IP-related tasks for the Development and Product teams. Offer expert advice on the application of IP rights in various countries and regions.
4. 法律文件管理:就知識產權和許可相關的法律文件的審查和起草提供法律咨詢,例如條款清單、保密協(xié)議(NDA)以及公司可能與合作伙伴簽訂的其他法律文件。
4.Legal Document Management: Provide legal counsel on the review and drafting of IP and licensing-related legal documents, such as term sheets, non-disclosure agreements (NDAs), and other legal documents the company may enter into with partners, primarily provided by the Business Development team.
5. 法律代表:代表公司回復電子郵件或答復與知識產權相關的請求,確保所有通信都符合法律標準和法規(guī)。
5.Legal Representation: Reply to emails or answer requests related to IP on behalf of the company, ensuring all communications are in compliance with legal standards and regulations.
6. 機構管理:就知識產權代理機構的選擇和管理提供建議,以優(yōu)化公司的知識產權組合和策略。
6.Agency Management: Offer advice on the selection and management of IP agencies to optimize the company's IP portfolio and strategy.
資質:
Qualifications:
1. 擁有法律執(zhí)業(yè)資格和專利代理人資格。
1.Possession of a legal practice qualification and patent attorney qualification.
2. 了解知識產權法律和實踐,包括維護和申請流程。
2.Knowledge of intellectual property laws and practices, including maintenance and application processes.
3. 能夠就國際知識產權權利和申請?zhí)峁I(yè)建議。
3.Ability to provide expert advice on international IP rights and applications.
4. 精通起草和審查與知識產權和許可相關的法律文件。
4.Proficiency in drafting and reviewing legal documents related to IP and licensing.
5. 擁有強大的溝通技巧,以代表公司處理與知識產權相關的通信。
5.Strong communication skills to represent the company in IP-related correspondence.
6. 有管理與知識產權代理機構的關系和為公司需求選擇合適的合作伙伴的經驗。
6.Experience in managing relationships with IP agencies and selecting appropriate partners for the company's needs.
7. 英文可作為工作語言。
薪資待遇:
30-40k * 14薪
投遞郵箱:
cierra.ding@jwtherapeutics.com
公司介紹
藥明巨諾(港交所代碼:2126)是一家獨立的、專注于開發(fā)、生產及商業(yè)化細胞免疫治療產品的創(chuàng)新型生物科技公司。藥明巨諾已打造了細胞免疫療法的技術與產品開發(fā)平臺,以及涵蓋血液及實體腫瘤、極具潛力的產品管線,以期為中國乃至全球患者帶來治愈的希望,并促進中國細胞免疫治療產業(yè)的健康規(guī)范發(fā)展。
JW Therapeutics (HKEx: 2126) is an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products. Founded in 2016, JW Therapeutics is committed to becoming an innovation leader ircell immunotherapy. The company has built a world.class platform for technology and product development in cell immunotherapy, as well as a promising product pipeline covering both hematologic malignancies and solid tumors, to bring the hope of a cure forChinese and global patients, and to lead the healthiand standardized development of China's cell immunotherapy industry.
(原標題:聘!藥明巨諾招聘「高級知識產權顧問」)
來源:IPRdaily中文網(iprdaily.cn)
編輯:IPRdaily辛夷 校對:IPRdaily縱橫君
注:原文鏈接:聘!藥明巨諾招聘「高級知識產權顧問」(點擊標題查看原文)
「關于IPRdaily」
IPRdaily是全球領先的知識產權綜合信息服務提供商,致力于連接全球知識產權與科技創(chuàng)新人才。匯聚了來自于中國、美國、歐洲、俄羅斯、以色列、澳大利亞、新加坡、日本、韓國等15個國家和地區(qū)的高科技公司及成長型科技企業(yè)的管理者及科技研發(fā)或知識產權負責人,還有來自政府、律師及代理事務所、研發(fā)或服務機構的全球近100萬用戶(國內70余萬+海外近30萬),2019年全年全網頁面瀏覽量已經突破過億次傳播。
(英文官網:iprdaily.com 中文官網:iprdaily.cn)
本文來自IPRdaily中文網(iprdaily.cn)并經IPRdaily.cn中文網編輯。轉載此文章須經權利人同意,并附上出處與作者信息。文章不代表IPRdaily.cn立場,如若轉載,請注明出處:“http://globalwellnesspartner.com
文章不錯,犒勞下辛苦的作者吧